NEW YORK (GenomeWeb) – German personalized cancer services company Indivumed said today that it has secured a €40 million ($47.7 million) loan from the European Investment Bank (EIB).

Indivumed said it will use the funding to develop and validate new biomarker assays for use in its biobank business and technology platforms, as well as build an information technology network that provides researchers worldwide with access to cancer patient data and bioinformatic tools.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.